226 related articles for article (PubMed ID: 26577751)
1. Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease.
Jayant S; Sharma BM; Bansal R; Sharma B
Pharmacol Biochem Behav; 2016 Jan; 140():39-50. PubMed ID: 26577751
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer's disease.
Jayant S; Sharma BM; Sharma B
Brain Res; 2016 Jul; 1642():397-408. PubMed ID: 27084583
[TBL] [Abstract][Full Text] [Related]
3. Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property.
Singh B; Sharma B; Jaggi AS; Singh N
J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):124-36. PubMed ID: 23060470
[TBL] [Abstract][Full Text] [Related]
4. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil.
Sharma B; Singh N; Singh M
J Psychopharmacol; 2008 Mar; 22(2):162-71. PubMed ID: 18208924
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type.
Kumar A; Singh N
Biomed Pharmacother; 2017 Apr; 88():698-707. PubMed ID: 28152479
[TBL] [Abstract][Full Text] [Related]
6. The effects of valsartan on cognitive deficits induced by aluminum trichloride and d-galactose in mice.
Yang WN; Hu XD; Han H; Shi LL; Feng GF; Liu Y; Qian YH
Neurol Res; 2014 Jul; 36(7):651-8. PubMed ID: 24620968
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid rescues memory deficits and neuropathological changes in mouse model of streptozotocin-induced dementia of Alzheimer's type.
Sodhi RK; Singh N
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():38-46. PubMed ID: 23044340
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of kinetin against aluminum chloride and D-galactose induced cognitive impairment and oxidative damage in mouse.
Wei Y; Liu D; Zheng Y; Li H; Hao C; Ouyang W
Brain Res Bull; 2017 Sep; 134():262-272. PubMed ID: 28867383
[TBL] [Abstract][Full Text] [Related]
9. Selective Modulator of Cannabinoid Receptor Type 2 Reduces Memory Impairment and Infarct Size During Cerebral Hypoperfusion and Vascular Dementia.
Jayant S; Sharma B
Curr Neurovasc Res; 2016; 13(4):289-302. PubMed ID: 27586843
[TBL] [Abstract][Full Text] [Related]
10. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
Ishrat T; Parveen K; Khan MM; Khuwaja G; Khan MB; Yousuf S; Ahmad A; Shrivastav P; Islam F
Brain Res; 2009 Jul; 1281():117-27. PubMed ID: 19374888
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease.
Kumar R; Kumar R; Sharma N; Khurana N; Singh SK; Satija S; Mehta M; Vyas M
Neurotoxicology; 2022 May; 90():19-34. PubMed ID: 35219781
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of thymoquinone on D-galactose and aluminum chloride induced neurotoxicity in rats: biochemical, histological and behavioral changes.
Abulfadl YS; El-Maraghy NN; Ahmed AAE; Nofal S; Badary OA
Neurol Res; 2018 Apr; 40(4):324-333. PubMed ID: 29464986
[TBL] [Abstract][Full Text] [Related]
13. Hypericum perforatum extract attenuates behavioral, biochemical, and neurochemical abnormalities in Aluminum chloride-induced Alzheimer's disease rats.
Cao Z; Wang F; Xiu C; Zhang J; Li Y
Biomed Pharmacother; 2017 Jul; 91():931-937. PubMed ID: 28514831
[TBL] [Abstract][Full Text] [Related]
14. Memory recuperative potential of rifampicin in aluminum chloride-induced dementia: role of pregnane X receptors.
Kaur P; Sodhi RK
Neuroscience; 2015 Mar; 288():24-36. PubMed ID: 25545714
[TBL] [Abstract][Full Text] [Related]
15. The effects of perindopril on cognitive impairment induced by d-galactose and aluminum trichloride via inhibition of acetylcholinesterase activity and oxidative stress.
Yang WN; Han H; Hu XD; Feng GF; Qian YH
Pharmacol Biochem Behav; 2013 Dec; 114-115():31-6. PubMed ID: 24201055
[TBL] [Abstract][Full Text] [Related]
16. Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.
Huang HC; Zheng BW; Guo Y; Zhao J; Zhao JY; Ma XW; Jiang ZF
J Alzheimers Dis; 2016 Apr; 52(3):899-911. PubMed ID: 27060945
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia.
Jain S; Sharma B
Physiol Behav; 2015 Dec; 152(Pt A):182-93. PubMed ID: 26382939
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of selenium against aluminum chloride-induced Alzheimer's disease: behavioral and biochemical alterations in rats.
Lakshmi BV; Sudhakar M; Prakash KS
Biol Trace Elem Res; 2015 May; 165(1):67-74. PubMed ID: 25613582
[TBL] [Abstract][Full Text] [Related]
19. Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet.
Sodhi RK; Singh N
PLoS One; 2013; 8(7):e70487. PubMed ID: 23936214
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia.
Kumar A; Kumar A; Jaggi AS; Singh N
Pharmacol Biochem Behav; 2015 Aug; 135():20-30. PubMed ID: 25987325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
